Compass Therapeutics, Inc.

NASDAQ:CMPX

Biotechnology

Healthcare
$0.61 -1.46%

-$0.03 today

Market cap
$109.26M
Beta
0.74
P/E (TTM)
-5.5
EPS (TTM)
-$0.37
52W Low $1.61High $6.88

Volume 2.90M

Average 7.64M

Price history

Compass Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-87.69%

Period high

$6.69

Period low

$0.61

Latest

$0.61

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GNov 10, 2026Nov 10, 2026
8-KNov 9, 2026Nov 9, 2026
10-QNov 9, 2026Nov 9, 2026
4Oct 2, 2026Oct 2, 2026
4Sep 25, 2026Sep 25, 2026
8-KSep 22, 2026Sep 22, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13GAug 7, 2026Aug 7, 2026
8-KAug 6, 2026Aug 6, 2026
10-QAug 6, 2026Aug 6, 2026
8-KJul 1, 2026Jul 1, 2026
8-KJun 23, 2026Jun 22, 2026
8-KJun 11, 2026Jun 11, 2026
SC 13G/AMay 15, 2026May 15, 2026
10-QMay 5, 2026May 5, 2026

Competitors

Who does Compass Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about CMPX's filings, answered from its disclosures.

What is the latest CMPX filing?

The latest filing shown is SC 13G dated Nov 10, 2026.

How many recent filings does CMPX have?

Intrinsic Alpha currently shows 20 recent filings for CMPX.